Table III.
Physical examination findings of transcriptional intermediary factor-1γ-positive versus -negative patients
| Variable | TIF-1γ positive* (n = 46), n (%) |
TIF-1γ negative (n = 76), n (%) |
P value† |
|---|---|---|---|
| Diffuse photoerythema | 21 (54) | 11 (17) | .00010 |
| Scalp rash | 40 (87) | 51 (69) | .029 |
| Facial rash | 43 (96) | 61 (81) | .028 |
| V-neck rash | 44 (98) | 56 (75) | .00070 |
| Back rash | 39 (87) | 60 (44) | .0033 |
| Lateral hip (holster) | 29 (71) | 24 (39) | .0020 |
| Psoriasis-like lesions | 6 (15) | 1 (1) | .0081 |
| Calcinosis | 1 (2) | 13 (18) | .0091 |
| “Red on white” | 5 (12) | 1 (1) | .023 |
| Palmar keratotic papules | 5 (12) | 1 (1) | .023 |
| Gottron papules | 31 (67) | 37 (49) | .060 |
| Periungual telangiectasias | 42 (91) | 58 (81) | .13 |
| Heliotrope | 36 (82) | 52 (70) | .19 |
| Alopecia | 25 (63) | 33 (49) | .23 |
| Palmar erythematous papules | 4 (9) | 11 (15) | .41 |
| Ulcers | 19 (41) | 25 (33) | .44 |
| Gottron sign | 35 (78) | 51 (72) | .52 |
TIF, Transcriptional intermediary factor.
*
TIF-1γ double-positive patients were excluded.
†
Fisher exact test.